Odongo Elizabeth A, Mutai Peggoty C, Amugune Beatrice K, Mungai Nelly N
Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, P.O. Box 19676-00202, Nairobi, Kenya.
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Nairobi, P.O. Box 19676-00202, Nairobi, Kenya.
Evid Based Complement Alternat Med. 2022 Mar 24;2022:9089360. doi: 10.1155/2022/9089360. eCollection 2022.
Kenya's vision 2030 partly aims at ensuring adequate health care for all, and the integration of traditional healthcare practices into the national healthcare system would present a more rapid alternative towards the realization of universal health coverage in Kenya. Currently, research on Kenyan medicinal plants with potential antibacterial activity remains vastly fragmented across numerous literature studies and databases; thus, it is imperative to collate and appraise these data for the ease of future research and possible clinical application. . This review aims at exploring and compiling research evidence on medicinal plants used in the management of bacterial infections in Kenya, with a focus on their efficacy and safety. . A comprehensive web-based systematic review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was executed to highlight the Kenyan medicinal plants used for the management of bacterial infections in Kenya. This review includes studies published until January 2021 from the PubMed, Science Direct, AJOL, and Google Scholar databases. . A total of 105 Kenyan medicinal plants belonging to 43 families have their activity against various human pathogenic bacteria evaluated. Plants from the Lamiaceae, Rutaceae, and Fabaceae families were the most commonly studied. , , , , , , and were the plants frequently evaluated within Kenya. The plants with the strongest antimicrobial activities were , , , , , , and . . Based on a published work, it is evident that traditional medicine is seemingly an acceptable and efficient system among Kenyan communities in the management of bacterial infections. Kenya's rich biodiversity with diverse secondary metabolites presents a promising source of new therapeutic alternatives with possibly different mechanisms of action against bacteria.
肯尼亚的“2030愿景”部分目标是确保全民享有充足的医疗保健,将传统医疗实践纳入国家医疗体系将为肯尼亚实现全民健康覆盖提供一条更快捷的途径。目前,关于具有潜在抗菌活性的肯尼亚药用植物的研究在众多文献研究和数据库中仍极为分散;因此,有必要整理和评估这些数据,以便于未来的研究和可能的临床应用。 本综述旨在探索和汇编关于肯尼亚用于治疗细菌感染的药用植物的研究证据,重点关注其疗效和安全性。 使用系统评价和Meta分析的首选报告项目(PRISMA)指南进行了全面的基于网络的系统评价,以突出肯尼亚用于治疗细菌感染的药用植物。本综述包括截至2021年1月在PubMed、Science Direct、AJOL和谷歌学术数据库上发表的研究。 共评估了43个科的105种肯尼亚药用植物对各种人类病原菌的活性。唇形科、芸香科和豆科的植物是研究最频繁的。 、 、 、 、 、 和 是在肯尼亚经常被评估的植物。抗菌活性最强的植物是 、 、 、 、 、 、 和 。 根据已发表的工作,很明显,传统医学在肯尼亚社区治疗细菌感染方面似乎是一个可接受且有效的系统。肯尼亚丰富的生物多样性和多样的次生代谢产物为新的治疗选择提供了一个有前景的来源,这些新的治疗选择可能具有针对细菌的不同作用机制。